Adeno-associated Virus Genome Population Sequencing Achieves Full Vector Genome Resolution and Reveals Human-Vector Chimeras
Recombinant adeno-associated virus (rAAV)-based gene therapy has entered a phase of clinical translation and commercialization. Despite this progress, vector integrity following production is often overlooked. Compromised vectors may negatively impact therapeutic efficacy and safety. Using single mo...
Main Authors: | Phillip W.L. Tai, Jun Xie, Kaiyuen Fong, Matthew Seetin, Cheryl Heiner, Qin Su, Michael Weiand, Daniella Wilmot, Maria L. Zapp, Guangping Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-06-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050118300147 |
Similar Items
-
AAV-Genome Population Sequencing of Vectors Packaging CRISPR Components Reveals Design-Influenced Heterogeneity
by: Ngoc Tam Tran, et al.
Published: (2020-09-01) -
In Situ Detection of Adeno-associated Viral Vector Genomes with SABER-FISH
by: Sean K. Wang, et al.
Published: (2020-12-01) -
Genome length determination in adeno-associated virus vectors with mass photometry
by: Cornelia Hiemenz, et al.
Published: (2023-12-01) -
Adeno-associated virus as a delivery vector for gene therapy of human diseases
by: Jiang-Hui Wang, et al.
Published: (2024-04-01) -
Predicted deleterious variants in the human genome relevant to gene therapy with adeno-associated virus vectors
by: Mahboubeh R. Rostami, et al.
Published: (2023-12-01)